БЛАНШЕТТ, Сара, Ф. (US),ФИЦДЖЕРАЛЬД, Джонатан, Бэзил (US),ГАДДИ, Дэниел, Ф. (US),ХЕНДРИКС, Барт, С. (US),КАЛРА, Ашиш (US),ЛИ, Хелен (US),БАЙЕВЕР, Элиел (US)
申请号：
RU2018105666
公开号：
RU2018105666A
申请日:
2016.08.19
申请国别(地区):
RU
年份:
2019
代理人:
摘要：
Combination therapy regimens including liposomal irinotecan, oxaliplatin and 5-fluorouracil are useful in the treatment of pancreatic cancer, including treatment of patients diagnosed with previously untreated metastatic adenocarcinoma of the pancreas. The combination therapy can include the administration of liposomal irinotecan, oxaliplatin, leucovorin and 5-fluorouracil once every two weeks.
